Logo

Thomas Weisel Partners

Thermo Fisher Strengthens PCR Portfolio with $260M Fermentas Acquisition
Premium

Thomas Weisel Partners called Thermo Fisher's planned $260 million acquisition of Fermentas a "synergistic tuck-in deal" that "bolsters Thermo's capabilities in the high-growth PCR market."

Cepheid Shares Downgraded by Bank

An investment analyst downgraded the shares to "market perform," citing the current hospital spending environment.

Bank Ups 2010 Revenue, EPS Estimates for Waters

The investment bank upped its estimates for the firm, citing a recent meeting with executives who said that they continue to see a stabilization in end markets.

Helicos Cuts Q3 Net Loss by Almost 40 Percent; Rules out Potential Sale of Company

Helicos said that based on its "improving standalone prospects and current market valuation" that it has disengaged from discussions involving a potential sale of the company.

Majority of Proteomic Stimulus Winners Not Likely to Buy Equipment, Analyst Report Finds
Premium

A Thomas Weisel Partners report found that some researchers do not plan to use the stimulus cash to buy equipment, such as mass specs. Rather, a majority said they would use the cash to hire additional personnel.
Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.